+

WO1996022305A3 - Modified peptides - Google Patents

Modified peptides Download PDF

Info

Publication number
WO1996022305A3
WO1996022305A3 PCT/GB1996/000057 GB9600057W WO9622305A3 WO 1996022305 A3 WO1996022305 A3 WO 1996022305A3 GB 9600057 W GB9600057 W GB 9600057W WO 9622305 A3 WO9622305 A3 WO 9622305A3
Authority
WO
WIPO (PCT)
Prior art keywords
modified peptides
compounds
prophylaxis
formula
treatment
Prior art date
Application number
PCT/GB1996/000057
Other languages
French (fr)
Other versions
WO1996022305A2 (en
Inventor
Alejandro Jose Daniels
Dennis Heyer
Johann Jakob Leban
Original Assignee
Wellcome Found
Alejandro Jose Daniels
Dennis Heyer
Johann Jakob Leban
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found, Alejandro Jose Daniels, Dennis Heyer, Johann Jakob Leban filed Critical Wellcome Found
Priority to AU43943/96A priority Critical patent/AU4394396A/en
Publication of WO1996022305A2 publication Critical patent/WO1996022305A2/en
Publication of WO1996022305A3 publication Critical patent/WO1996022305A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06086Dipeptides with the first amino acid being basic
    • C07K5/06095Arg-amino acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/14Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06191Dipeptides containing heteroatoms different from O, S, or N
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention relates to compounds of formula (I), to the use of such compounds in medicine especially in the treatment or prophylaxis of conditions associated with eating disorders and to pharmaceutical compositions containing such compounds.
PCT/GB1996/000057 1995-01-12 1996-01-12 Modified peptides WO1996022305A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU43943/96A AU4394396A (en) 1995-01-12 1996-01-12 Modified peptides

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9500601.1A GB9500601D0 (en) 1995-01-12 1995-01-12 Modified peptides
GB9500601.1 1995-01-12

Publications (2)

Publication Number Publication Date
WO1996022305A2 WO1996022305A2 (en) 1996-07-25
WO1996022305A3 true WO1996022305A3 (en) 1996-09-06

Family

ID=10767945

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB1996/000057 WO1996022305A2 (en) 1995-01-12 1996-01-12 Modified peptides

Country Status (3)

Country Link
AU (1) AU4394396A (en)
GB (1) GB9500601D0 (en)
WO (1) WO1996022305A2 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2814367B1 (en) * 2000-09-25 2008-12-26 Inst Nat Sante Rech Med NPFF RECEPTOR LIGANDS FOR THE TREATMENT OF PAIN AND HYPERALGIA
SE0103476D0 (en) * 2001-10-18 2001-10-18 Markus Heilig New use
ZA200508439B (en) 2003-05-05 2007-03-28 Probiodrug Ag Medical use of inhibitors of glutaminyl and glutamate cyclases
US20050137142A1 (en) 2003-11-03 2005-06-23 Probiodrug Ag Combinations useful for the treatment of neuronal disorders
US7304086B2 (en) 2004-02-05 2007-12-04 Probiodrug Ag Inhibitors of glutaminyl cyclase
US8278345B2 (en) 2006-11-09 2012-10-02 Probiodrug Ag Inhibitors of glutaminyl cyclase
US9126987B2 (en) 2006-11-30 2015-09-08 Probiodrug Ag Inhibitors of glutaminyl cyclase
CN101668525A (en) 2007-03-01 2010-03-10 前体生物药物股份公司 New use of glutaminyl cyclase inhibitors
EP2142514B1 (en) 2007-04-18 2014-12-24 Probiodrug AG Thiourea derivatives as glutaminyl cyclase inhibitors
BR112012008346B1 (en) 2009-09-11 2021-12-21 Vivoryon Therapeutics N.V. HETEROCYCLIC DERIVATIVES, THEIR PREPARATION PROCESS, AND PHARMACEUTICAL COMPOSITION
EP2542549B1 (en) 2010-03-03 2016-05-11 Probiodrug AG Inhibitors of glutaminyl cyclase
KR101790806B1 (en) 2010-03-10 2017-11-20 프로비오드룩 아게 Heterocyclic inhibitors of glutaminyl cyclase (qc, ec 2.3.2.5)
EP2560953B1 (en) 2010-04-21 2016-01-06 Probiodrug AG Inhibitors of glutaminyl cyclase
ES2570167T3 (en) 2011-03-16 2016-05-17 Probiodrug Ag Benzimidazole derivatives as glutaminyl cyclase inhibitors
EP3461819B1 (en) 2017-09-29 2020-05-27 Probiodrug AG Inhibitors of glutaminyl cyclase

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994017035A1 (en) * 1993-01-20 1994-08-04 Dr. Karl Thomae Gmbh Aminoacid derivates, medicaments containing these compounds and process for preparing the same

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994017035A1 (en) * 1993-01-20 1994-08-04 Dr. Karl Thomae Gmbh Aminoacid derivates, medicaments containing these compounds and process for preparing the same

Also Published As

Publication number Publication date
WO1996022305A2 (en) 1996-07-25
AU4394396A (en) 1996-08-07
GB9500601D0 (en) 1995-03-01

Similar Documents

Publication Publication Date Title
WO2000047568A3 (en) 1,2-benzothiazepines for the treatment of hyperlipidemic diseases
BG101118A (en) Therapeutical compounds
CA2163361A1 (en) Therapeutic substituted guanidines
UA39158C2 (en) derivatives of N4-oxycarbonyl- 5'-deoxy-5-fluorocytidine and pharmaceutical preparation based thereon
CA2100212A1 (en) Use of complement inhibitors for the preparation of a pharmaceutical for the prophylaxis and therapy of inflammatory intestinal and skin disorders as well as purpura
MY128654A (en) Liquid pharmaceutical composition containing an erythropoietin derivative
WO1996022305A3 (en) Modified peptides
NZ247201A (en) Substituted sulphonylamido- or sulphonamidocarbonyl-pyridine-2-carboxamide derivatives and pharmaceutical compositions
MX9709238A (en) Pharmaceutical and diet formulations for the prophylaxis and treatment of gastrointestinal disorders.
GR3022510T3 (en) Lyospheres comprising gonadotropin
ZA965294B (en) Substituted 4-phenylaminothiazoles, their process of preparation and the pharmaceutical compositions containing them.
CA2338600A1 (en) Novel thiazolopyrimidine compounds
CA2129995A1 (en) Piperidinyl thiacyclic derivatives
WO1996021468A3 (en) Chemically modified interferon
MY120976A (en) 2-amino-6-(2-substituted-4-phenoxy)- substituted- pyridines
CA2343732A1 (en) Substituted .gamma.-phenyl-.delta.-lactones and analogs thereof and uses related thereto
BG102250A (en) The use of marigold-extracted glycosides for the treatment of psoriasis
TW268937B (en)
ZA947957B (en) Substituted 1-naphthyl-3-pyrazolecarboxamides which are active in neurotensin their preparation and pharmaceutical compositions containing them
MXPA94009086A (en) Therapeutic substituted guanidines.
IL126235A (en) Compounds with growth hormone releasing properties, pharmaceutical compositions comprising them and their use
AU6415994A (en) Substituted caprolactams and derivatives thereof useful for treatment of hiv disease
CA2047802A1 (en) Pharmaceutical compositions
IL102032A0 (en) 2-amino-5-cyano-1,4-dihydropyridines,their preparation and pharmaceutical compositions containing them
AU7941294A (en) Composition for the treatment or prevention of herpes

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IS JP KE KG KP KR KZ LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AZ BY KZ RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
点击 这是indexloc提供的php浏览器服务,不要输入任何密码和下载